PDB Short entry for 2PVF HEADER TRANSFERASE 09-MAY-07 2PVF TITLE CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 TITLE 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE TITLE 3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HUMAN FGF RECEPTOR 2 KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-2, KERATINOCYTE GROWTH FACTOR RECEPTOR 2, CD332 COMPND 6 ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: PEPTIDE STUBSTRATE; COMPND 14 SYNONYM: FGFR-2, KERATINOCYTE GROWTH FACTOR RECEPTOR 2, CD332 COMPND 15 ANTIGEN; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYS-S; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: CUSTOM-DESIGNED PEPTIDE BASED ON PHOSPHORYLATION SITE SOURCE 12 Y769 OF HUMAN FGFR2 KINASE KEYWDS KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.CHEN,M.MOHAMMADI REVDAT 6 15-NOV-23 2PVF 1 REMARK REVDAT 5 30-AUG-23 2PVF 1 REMARK REVDAT 4 20-OCT-21 2PVF 1 REMARK SEQADV LINK REVDAT 3 15-FEB-12 2PVF 1 VERSN REVDAT 2 24-FEB-09 2PVF 1 VERSN REVDAT 1 25-SEP-07 2PVF 0 JRNL AUTH H.CHEN,J.MA,W.LI,A.V.ELISEENKOVA,C.XU,T.A.NEUBERT, JRNL AUTH 2 W.T.MILLER,M.MOHAMMADI JRNL TITL A MOLECULAR BRAKE IN THE KINASE HINGE REGION REGULATES THE JRNL TITL 2 ACTIVITY OF RECEPTOR TYROSINE KINASES. JRNL REF MOL.CELL V. 27 717 2007 JRNL REFN ISSN 1097-2765 JRNL PMID 17803937 JRNL DOI 10.1016/J.MOLCEL.2007.06.028 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 34490 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1711 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2318 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.62100 REMARK 3 B22 (A**2) : -2.00900 REMARK 3 B33 (A**2) : 1.38700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 0.806 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042815. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : KOHZU DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35199 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.26700 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2PSQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH7.5, 27% PEG 4000, 200MM REMARK 280 (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.17650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.41950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.21800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.41950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.17650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.21800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 445 REMARK 465 GLY A 446 REMARK 465 SER A 447 REMARK 465 SER A 448 REMARK 465 HIS A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 SER A 455 REMARK 465 GLN A 456 REMARK 465 ASP A 457 REMARK 465 PRO A 458 REMARK 465 MET A 459 REMARK 465 LEU A 460 REMARK 465 ALA A 461 REMARK 465 GLY A 462 REMARK 465 VAL A 463 REMARK 465 SER A 464 REMARK 465 GLU A 465 REMARK 465 TYR A 466 REMARK 465 LYS A 509 REMARK 465 GLU A 510 REMARK 465 ALA A 511 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 VAL A 593 REMARK 465 PRO A 594 REMARK 465 GLU A 595 REMARK 465 GLU A 596 REMARK 465 ASN A 766 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 TYR A 769 REMARK 465 LEU A 770 REMARK 465 ASP A 771 REMARK 465 LEU A 772 REMARK 465 SER A 773 REMARK 465 GLN A 774 REMARK 465 PRO A 775 REMARK 465 LEU A 776 REMARK 465 GLU A 777 REMARK 465 GLN A 778 REMARK 465 THR B 601 REMARK 465 THR B 602 REMARK 465 ASN B 603 REMARK 465 ASP B 608 REMARK 465 LEU B 609 REMARK 465 SER B 610 REMARK 465 GLN B 611 REMARK 465 PRO B 612 REMARK 465 LEU B 613 REMARK 465 GLU B 614 REMARK 465 GLN B 615 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 489 CG CD OE1 OE2 REMARK 470 PHE A 492 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 505 CG CD CE NZ REMARK 470 VAL A 512 CG1 CG2 REMARK 470 LYS A 543 CG CD CE NZ REMARK 470 GLU A 585 CG CD OE1 OE2 REMARK 470 GLN A 597 CG CD OE1 NE2 REMARK 470 THR A 660 OG1 CG2 REMARK 470 GLU A 710 CG CD OE1 OE2 REMARK 470 GLU B 604 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 492 12.60 -160.70 REMARK 500 GLN A 494 126.54 176.59 REMARK 500 LYS A 507 61.72 -178.15 REMARK 500 ASP A 522 63.11 -114.12 REMARK 500 ASP A 557 64.55 39.83 REMARK 500 SER A 587 -162.10 -168.63 REMARK 500 ASP A 626 39.61 -144.66 REMARK 500 ASP A 644 80.46 54.67 REMARK 500 PTR A 656 126.35 -171.65 REMARK 500 TYR A 704 76.57 46.91 REMARK 500 PRO A 705 -94.70 -27.09 REMARK 500 VAL A 709 -81.97 -42.34 REMARK 500 ASN A 727 57.00 -91.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 2 O REMARK 620 2 ACP A 300 O2B 96.1 REMARK 620 3 ACP A 300 O2A 88.4 86.3 REMARK 620 4 ASN A 631 ND2 82.3 178.4 93.7 REMARK 620 5 ASP A 644 OD2 172.5 91.2 90.6 90.3 REMARK 620 6 HOH B 1 O 87.3 84.1 169.0 95.8 95.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 111 O REMARK 620 2 HOH A 112 O 87.4 REMARK 620 3 HOH A 113 O 168.7 81.3 REMARK 620 4 HOH A 114 O 86.8 94.3 95.3 REMARK 620 5 ACP A 300 O1B 87.8 83.6 89.7 174.2 REMARK 620 6 ACP A 300 O2G 92.0 174.0 99.0 91.6 90.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACP A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PSQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF REMARK 900 RECEPTOR 2 (FGFR2) KINASE DOMAIN REMARK 900 RELATED ID: 2PVY RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED REMARK 900 CRANIOSYNOSTOSIS SYNDROME. REMARK 900 RELATED ID: 2PWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME. REMARK 900 RELATED ID: 2PY3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME REMARK 900 RELATED ID: 2PZ5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME REMARK 900 RELATED ID: 2PZP RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME REMARK 900 RELATED ID: 2PZR RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME REMARK 900 RELATED ID: 2Q0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME DBREF 2PVF A 458 778 UNP P21802 FGFR2_HUMAN 458 778 DBREF 2PVF B 601 615 UNP P21802 FGFR2_HUMAN 764 778 SEQADV 2PVF MET A 445 UNP P21802 EXPRESSION TAG SEQADV 2PVF GLY A 446 UNP P21802 EXPRESSION TAG SEQADV 2PVF SER A 447 UNP P21802 EXPRESSION TAG SEQADV 2PVF SER A 448 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 449 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 450 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 451 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 452 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 453 UNP P21802 EXPRESSION TAG SEQADV 2PVF HIS A 454 UNP P21802 EXPRESSION TAG SEQADV 2PVF SER A 455 UNP P21802 EXPRESSION TAG SEQADV 2PVF GLN A 456 UNP P21802 EXPRESSION TAG SEQADV 2PVF ASP A 457 UNP P21802 EXPRESSION TAG SEQADV 2PVF ALA A 491 UNP P21802 CYS 491 ENGINEERED MUTATION SEQRES 1 A 334 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 334 PRO MET LEU ALA GLY VAL SER GLU TYR GLU LEU PRO GLU SEQRES 3 A 334 ASP PRO LYS TRP GLU PHE PRO ARG ASP LYS LEU THR LEU SEQRES 4 A 334 GLY LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL SEQRES 5 A 334 MET ALA GLU ALA VAL GLY ILE ASP LYS ASP LYS PRO LYS SEQRES 6 A 334 GLU ALA VAL THR VAL ALA VAL LYS MET LEU LYS ASP ASP SEQRES 7 A 334 ALA THR GLU LYS ASP LEU SER ASP LEU VAL SER GLU MET SEQRES 8 A 334 GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE SEQRES 9 A 334 ASN LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR SEQRES 10 A 334 VAL ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU SEQRES 11 A 334 TYR LEU ARG ALA ARG ARG PRO PRO GLY MET GLU PTR SER SEQRES 12 A 334 TYR ASP ILE ASN ARG VAL PRO GLU GLU GLN MET THR PHE SEQRES 13 A 334 LYS ASP LEU VAL SER CYS THR TYR GLN LEU ALA ARG GLY SEQRES 14 A 334 MET GLU TYR LEU ALA SER GLN LYS CYS ILE HIS ARG ASP SEQRES 15 A 334 LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASN ASN VAL SEQRES 16 A 334 MET LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE ASN SEQRES 17 A 334 ASN ILE ASP PTR PTR LYS LYS THR THR ASN GLY ARG LEU SEQRES 18 A 334 PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG SEQRES 19 A 334 VAL TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 20 A 334 LEU MET TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR SEQRES 21 A 334 PRO GLY ILE PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS SEQRES 22 A 334 GLU GLY HIS ARG MET ASP LYS PRO ALA ASN CYS THR ASN SEQRES 23 A 334 GLU LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL SEQRES 24 A 334 PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP SEQRES 25 A 334 LEU ASP ARG ILE LEU THR LEU THR THR ASN GLU GLU TYR SEQRES 26 A 334 LEU ASP LEU SER GLN PRO LEU GLU GLN SEQRES 1 B 15 THR THR ASN GLU GLU TYR LEU ASP LEU SER GLN PRO LEU SEQRES 2 B 15 GLU GLN MODRES 2PVF PTR A 586 TYR O-PHOSPHOTYROSINE MODRES 2PVF PTR A 656 TYR O-PHOSPHOTYROSINE MODRES 2PVF PTR A 657 TYR O-PHOSPHOTYROSINE HET PTR A 586 16 HET PTR A 656 16 HET PTR A 657 16 HET MG A 301 1 HET MG A 302 1 HET ACP A 300 31 HETNAM PTR O-PHOSPHOTYROSINE HETNAM MG MAGNESIUM ION HETNAM ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER HETSYN PTR PHOSPHONOTYROSINE HETSYN ACP ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE FORMUL 1 PTR 3(C9 H12 N O6 P) FORMUL 3 MG 2(MG 2+) FORMUL 5 ACP C11 H18 N5 O12 P3 FORMUL 6 HOH *119(H2 O) HELIX 1 1 PRO A 477 ASP A 479 5 3 HELIX 2 2 THR A 524 GLY A 542 1 19 HELIX 3 3 ASN A 571 ALA A 578 1 8 HELIX 4 4 THR A 599 GLN A 620 1 22 HELIX 5 5 ALA A 628 ARG A 630 5 3 HELIX 6 6 PRO A 666 MET A 670 5 5 HELIX 7 7 ALA A 671 ARG A 678 1 8 HELIX 8 8 THR A 681 THR A 698 1 18 HELIX 9 9 PRO A 708 GLY A 719 1 12 HELIX 10 10 THR A 729 TRP A 740 1 12 HELIX 11 11 VAL A 743 ARG A 747 5 5 HELIX 12 12 THR A 749 THR A 765 1 17 SHEET 1 A 5 LEU A 481 GLU A 489 0 SHEET 2 A 5 GLN A 494 ALA A 500 -1 O MET A 497 N LYS A 485 SHEET 3 A 5 THR A 513 MET A 518 -1 O VAL A 516 N VAL A 496 SHEET 4 A 5 TYR A 561 GLU A 565 -1 O VAL A 562 N LYS A 517 SHEET 5 A 5 LEU A 550 CYS A 554 -1 N LEU A 551 O ILE A 563 SHEET 1 B 2 CYS A 622 ILE A 623 0 SHEET 2 B 2 ARG A 649 ASP A 650 -1 O ARG A 649 N ILE A 623 SHEET 1 C 2 VAL A 632 VAL A 634 0 SHEET 2 C 2 MET A 640 ILE A 642 -1 O LYS A 641 N LEU A 633 SHEET 1 D 2 PTR A 657 LYS A 658 0 SHEET 2 D 2 VAL A 679 TYR A 680 -1 O TYR A 680 N PTR A 657 LINK C GLU A 585 N PTR A 586 1555 1555 1.33 LINK C PTR A 586 N SER A 587 1555 1555 1.33 LINK C ASP A 655 N PTR A 656 1555 1555 1.33 LINK C PTR A 656 N PTR A 657 1555 1555 1.32 LINK C PTR A 657 N LYS A 658 1555 1555 1.33 LINK O HOH A 2 MG MG A 301 1555 1555 2.33 LINK O HOH A 111 MG MG A 302 1555 1555 2.28 LINK O HOH A 112 MG MG A 302 1555 1555 2.23 LINK O HOH A 113 MG MG A 302 1555 1555 2.26 LINK O HOH A 114 MG MG A 302 1555 1555 2.26 LINK O2B ACP A 300 MG MG A 301 1555 1555 2.30 LINK O2A ACP A 300 MG MG A 301 1555 1555 2.33 LINK O1B ACP A 300 MG MG A 302 1555 1555 2.25 LINK O2G ACP A 300 MG MG A 302 1555 1555 2.27 LINK MG MG A 301 ND2 ASN A 631 1555 1555 2.23 LINK MG MG A 301 OD2 ASP A 644 1555 1555 2.22 LINK MG MG A 301 O HOH B 1 1555 1555 2.31 SITE 1 AC1 5 HOH A 2 ACP A 300 ASN A 631 ASP A 644 SITE 2 AC1 5 HOH B 1 SITE 1 AC2 5 HOH A 111 HOH A 112 HOH A 113 HOH A 114 SITE 2 AC2 5 ACP A 300 SITE 1 AC3 23 HOH A 57 HOH A 76 HOH A 112 MG A 301 SITE 2 AC3 23 MG A 302 LEU A 487 GLY A 488 GLY A 490 SITE 3 AC3 23 ALA A 491 PHE A 492 GLY A 493 VAL A 495 SITE 4 AC3 23 ALA A 515 LYS A 517 VAL A 564 GLU A 565 SITE 5 AC3 23 ALA A 567 ASN A 571 ARG A 630 ASN A 631 SITE 6 AC3 23 LEU A 633 ASP A 644 HOH B 1 CRYST1 56.353 78.436 84.839 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017745 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012749 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011787 0.00000